Kalytera Therapeutics Inc.
this company is on the move good buy at 0.08 hot stock
Kalytera Therapeutics Inc develops cannabinoid (CBD) therapeutics for a range of unmet medical needs. CBD is a compound that shows activity against various pharmacological targets. The company develops CBD formulations and prodrugs to target specific disease sites within the body. Its programs include Bone Fracture Healing Program, Osteogenesis Imperfecta Program, Osteoporosis Program, and Osteoporosis in Prader-Willi syndrome.”